Your browser doesn't support javascript.
loading
Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Keita, Adama Mamby; Doh, Sanogo; Sow, Samba O; Powell, Helen; Omore, Richard; Jahangir Hossain, M; Ogwel, Billy; Ochieng, John B; Jones, Joquina Chiquita M; Zaman, Syed M A; Awuor, Alex O; Juma, Jane; Nasrin, Dilruba; Liu, Jie; Traoré, Awa; Onwuchekwa, Uma; Badji, Henry; Sarwar, Golam; Antonio, Martin; Houpt, Eric R; Tennant, Sharon M; Kasumba, Irene N; Jamka, Leslie P; Roose, Anna; Platts-Mills, James A; Verani, Jennifer R; Tate, Jacqueline E; Parashar, Umesh D; Neuzil, Kathleen M; Kotloff, Karen L.
Afiliação
  • Keita AM; Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
  • Doh S; Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
  • Sow SO; Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
  • Powell H; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Omore R; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Jahangir Hossain M; Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
  • Ogwel B; Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
  • Ochieng JB; Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
  • Jones JCM; Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
  • Zaman SMA; Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
  • Awuor AO; Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
  • Juma J; Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
  • Nasrin D; Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.
  • Liu J; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Traoré A; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Onwuchekwa U; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Badji H; Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
  • Sarwar G; Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
  • Antonio M; Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
  • Houpt ER; Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
  • Tennant SM; Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
  • Kasumba IN; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Jamka LP; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Roose A; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Platts-Mills JA; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Verani JR; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Tate JE; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Parashar UD; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Kotloff KL; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Clin Infect Dis ; 76(76 Suppl1): S123-S131, 2023 04 19.
Article em En | MEDLINE | ID: mdl-37074439
ABSTRACT

BACKGROUND:

While rotavirus causes severe diarrheal disease in children aged <5 years, data on other viral causes in sub-Saharan Africa are limited.

METHODS:

In the Vaccine Impact on Diarrhea in Africa study (2015-2018), we analyzed stool from children aged 0-59 months with moderate-to-severe diarrhea (MSD) and without diarrhea (controls) in Kenya, Mali, and The Gambia using quantitative polymerase chain reaction. We derived the attributable fraction (AFe) based on the association between MSD and the pathogen, accounting for other pathogens, site, and age. A pathogen was attributable if the AFe was ≥0.5.The severity of attributable MSD was defined by a modified Vesikari score (mVS). Monthly cases were plotted against temperature and rainfall to assess seasonality.

RESULTS:

Among 4840 MSD cases, proportions attributed to rotavirus, adenovirus 40/41, astrovirus, and sapovirus were 12.6%, 2.7%, 2.9%, and 1.9%, respectively. Attributable rotavirus, adenovirus 40/41, and astrovirus MSD cases occurred at all sites, with mVS of 11, 10, and 7, respectively. MSD cases attributable to sapovirus occurred in Kenya, with mVS of 9. Astrovirus and adenovirus 40/41 peaked during the rainy season in The Gambia, while rotavirus peaked during the dry season in Mali and The Gambia.

CONCLUSIONS:

In sub-Saharan Africa, rotavirus was the most common cause of MSD; adenovirus 40/41, astrovirus, and sapovirus contributed to a lesser extent among children aged <5 years. Rotavirus- and adenovirus 40/41-attributable MSD were most severe. Seasonality varied by pathogen and location. Efforts to increase the coverage of rotavirus vaccines and to improve prevention and treatment for childhood diarrhea should continue.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus de RNA / Vacinas / Rotavirus / Sapovirus Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans / Infant País como assunto: Africa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus de RNA / Vacinas / Rotavirus / Sapovirus Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans / Infant País como assunto: Africa Idioma: En Ano de publicação: 2023 Tipo de documento: Article